FindTrial
Sign In

The effect of High Definition- Transcranial Direct Current Stimulation on patients with chronic pain

Effect of HD- tDCS on pain in somatic symptom disorder: a randomized single-blind sham controlled cross-over study - HD- tDCS: High Definition Transcranial Direct Current Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028752
Enrollment
36
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F454- Pain disorders related to psychological factors

Interventions

Intervention1: High definition transcranial direct current stimulation: High definition transcranial direct current stimulation, 2 active sessions of 2mA and 20 minutes each with interval of 30 minute

Sponsors

Sanjana K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Providing written informed consent 2.already receiving any form of treatment - pharmacological or non pharmacological ( with no change in the past 3 months)

Exclusion criteria

Exclusion criteria: Patients who do not give consent for study ââ?¬Â¢ Patients with diagnosed Parkinsonââ?¬•s disease, organic brain syndrome, intellectual disability, dementia, multiple sclerosis or known diabetes mellitus ââ?¬Â¢ Patients with history of head injury, epilepsy, encephalopathy due to any cause or neurological procedures ââ?¬Â¢ Presence of other cross-sectional or lifetime comorbid psychiatric disorders (as determined by using MINI, except cross-sectional diagnosis of an anxiety or depressive disorder) ââ?¬Â¢ Pregnant females

Design outcomes

Primary

MeasureTime frame
2 sessions of active HD-tDCS on the left motor cortex(M1) produces 30% reduction of NRS score within a period of 2 weeksTimepoint: 2 sessions of active HD-tDCS on the left motor cortex(M1) produces 30% reduction of NRS score within a period of 2 weeks—

Secondary

MeasureTime frame
a) impression of change b) cognitive functions c) self-reported disability d) burden e) quality of life f) depressive symptom g) incidence and nature of adverse effectsTimepoint: 2 weeks, 4 weeks—

Countries

India

Contacts

Public ContactSanjana K

PGIMER

shubhmohan@gmail.com9417249900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026